FibroScint
Thrombus imaging in patients with mechanical assist devices
ApprovedActive
Key Facts
Indication
Thrombus imaging in patients with mechanical assist devices
Phase
Approved
Status
Active
About NorthStar Medical Technologies
NorthStar Medical Technologies is a pioneering radiopharmaceutical company specializing in the non-uranium, accelerator-based production of therapeutic radioisotopes, notably Ac-225 and Cu-67. Its integrated campus houses the technology, facilities, and expertise to serve as a critical CDMO/CMO, addressing supply chain challenges in the rapidly growing targeted radioligand therapy field. The company is positioned as a near-term commercial-scale producer of these high-demand isotopes, supported by strategic partnerships and a pipeline of development programs aimed at expanding treatment options for various cancers.
View full company profile